Use access key #2 to skip to page content.

jiltin (46.04)

RNA, My new test stock



July 11, 2013 – Comments (4) | RELATED TICKERS: RNA.DL

 Only 19 pitches made so far at, but few positive pitches.Based on pitch made by pchop123, I reviewed the details why RNA is going crazy. 

I came across 

 I always pitch and buy to match my prediction. This time carefully bought 50 shares and it rocks with 20%. 

I do not plan to day-trade if it reaches another 20% and keep this as long term investment.  This is what I am planning.

I just want to scribe what I do.

Sorry for my rant.  


4 Comments – Post Your Own

#1) On July 11, 2013 at 3:34 PM, awallejr (34.04) wrote:

I actually like PTCT.  That's an awful lot of insider buying.

Report this comment
#2) On July 11, 2013 at 11:56 PM, jiltin (46.04) wrote:

Yes, I have seen this. There is a reason for this stock (hype or real) that it has received "Breakthrough" status from FDA recently after IPO is public.

Read wallstreet moneybeat

NEA and Glaxo bought Prosensa stock in the IPO, according to the prospectus.

Glaxo is sales channel for this product.

Menlo Park, Calif.-based venture capital firm. NEA

I still do not know whether this is worth or not. However, keeping it long term at least trying for an year.



Report this comment
#3) On July 12, 2013 at 12:54 PM, constructive (99.97) wrote:

What are you testing exactly?

What does "carefully" buying 50 shares mean?

If you are describing your careful investment process, surely that would involve your own analysis and not just linking to Seeking Alpha and WSJ articles?

What will you do if the stock doesn't go up another 20%? Also hold it for a year? 

Report this comment
#4) On November 08, 2013 at 1:03 AM, jiltin (46.04) wrote:

Sorry for late reply. I sold it profitable, but later it went down 75%. Great escape for me.

Report this comment

Featured Broker Partners